Stocktoria
REGENEREX PHARMA, INC. RGPX
OTC · stock · Pharmaceutical Preparations · website · IPO 2008-09-08
REGENEREX PHARMA, INC. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | -13798.1% | 34.4% | — | — | — | — |
| Operating margin | — | — | — | — | -2445.7% | -2952.6% | — | — | — | — |
| Net margin | — | — | — | — | -19929.7% | 4278.7% | — | — | — | -10620.0% |
| Return on assets | -200.0% | -462.2% | -2100.2% | -1276.5% | -3378.7% | 43.1% | -88.6% | -329.6% | 22514.5% | -6588.2% |
| Return on equity | 60.8% | 87.2% | 12.2% | 19.8% | 42.4% | -23.2% | 25.3% | 15.5% | -108.1% | 132.1% |
| Debt / equity | — | -0.05× | — | — | — | — | — | — | — | — |
| Current ratio | 0.13 | 0.00 | 0.00 | 0.01 | 0.01 | 0.49 | 0.24 | 0.01 | — | 0.02 |
Source: SEC EDGAR filings · CIK 0001357878 · US · as of 2025-03-31. facts plus Stocktoria's own computed scores — not investment advice.